Purevax RCPCh Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcpch

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain), attenuated feline panleucopenia virus (pli iv) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:• against feline viral rhinotracheitis to reduce clinical signs;• against calicivirus infection to reduce clinical signs;• against chlamydophila felis infection to reduce clinical signs;• against feline panleucopenia to prevent mortality and clinical signs. Οι αντιδράσεις ανοσίας έχουν αποδειχθεί μία εβδομάδα μετά την αρχική πορεία εμβολιασμού για ρινοτραχειίτιδα, καλυκοϊό, συστατικά chlamydophila felis και παγκρεακοπενία. the duration of immunity is one year after the last re-vaccination for the chlamydiosis component, and oneyear after primary vaccination and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RCCh Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcch

merial - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated chlamydophila felis (905 strain) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs and excretion;against chlamydophila felis infection to reduce clinical signs. Τα αντισώματα ανοσίας έχουν αποδειχθεί 1 εβδομάδα μετά τον κύριο εμβολιασμό για ρινοτραχειίτιδα, καλυκοϊό και συστατικά chlamydophila felis. Η διάρκεια της ανοσίας είναι 1 έτος μετά τον τελευταίο (επαν) εμβολιασμό.

Purevax RCPCh FeLV Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcpch felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97), attenuated chlamydophila felis (905 strain) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against chlamydophila felis infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus, chlamydophila felis and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the chlamydiosis and feline leukaemia components, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

Purevax RCP FeLV Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcp felv

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains), attenuated feline panleucopenia virus (pli iv), felv recombinant canarypox virus (vcp97) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged 8 weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs ;against feline panleucopenia to prevent mortality and clinical signs;against leukaemia to prevent persistent viraemia and clinical signs of the related disease. onsets of immunity are 1 week after primary vaccination course for rhinotracheitis, calicivirus and panleucopenia components, and 2 weeks after primary vaccination course for feline leukaemia component. the duration of immunity is one year after the last re-vaccination for the feline leukaemia component, and one year after primary vaccination course and three years after the last re-vaccination for the rhinotracheitis, calicivirosis and panleucopenia components.

FELIVAC PCHR - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

felivac pchr - ενεσιμο γαλακτωμα

ΚΑΝΔΗΛΙΔΗ Α.Ε. Δ.Τ. candilidis sa (0000014548) Λεωφ. Κύμης & Ηλέκτρας 4β,15122,Μαρούσι, Αττική,gr - rabies virus, strain sad vnukovo-32; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain); inactivated feline calicivirus, strain 255; attenuated feline panleucopenia virus (pli iv) - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - - - rabies virus, strain sad vnukovo-32 0,00 em.inj -; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 em.inj -; inactivated feline calicivirus, strain 255 0,00 em.inj -; attenuated feline panleucopenia virus (pli iv) 0,00 em.inj - - feline panleucopenia virus + feline calcivirus + feline rhinotracheitis virus + rabies virus - Γάτες - Χρόνοι αναμονής: Γάτες

FELIVAC PCH - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

felivac pch - ενεσιμο γαλακτωμα

ΚΑΝΔΗΛΙΔΗ Α.Ε. Δ.Τ. candilidis sa (0000014548) Λεωφ. Κύμης & Ηλέκτρας 4β,15122,Μαρούσι, Αττική,gr - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain); attenuated feline panleucopenia virus (pli iv); inactivated feline calicivirus, strain 255 - ΕΝΕΣΙΜΟ ΓΑΛΑΚΤΩΜΑ - - - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 em.inj -; attenuated feline panleucopenia virus (pli iv) 0,00 em.inj -; inactivated feline calicivirus, strain 255 0,00 em.inj - - feline rhinotracheitis virus + feline calicivirus + feline panleucopenia virus / parvovirus - Γάτες - Χρόνοι αναμονής: Γάτες

PUREVAX RC ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

purevax rc λυοφιλοποιημενο υλικο και διαλυτησ για ενεσιμο εναιωρημα

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - inactivated feline calicivirus (fcv 431 and g1 strains) antigens 2,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + inactivated feline calicivirus antigen - Γάτες - Χρόνοι αναμονής: Γάτες

Purevax RC Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rc

boehringer ingelheim vetmedica gmbh - attenuated feline rhinotracheitis herpesvirus (fhv f2 strain), inactivated feline calicivirosis antigens (fcv 431 and g1 strains) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs. onsets of immunity isone week after primary vaccination course. the duration of immunity is one year after primary vaccination course and three years after the last re-vaccination.

Purevax RCP Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

purevax rcp

boehringer ingelheim vetmedica gmbh - attenuated feline panleucopenia virus (pli iv) - Ανοσολογικά για αιλουροειδών, - Γάτες - active immunisation of cats aged eight weeks and older:against feline viral rhinotracheitis to reduce clinical signs;against calicivirus infection to reduce clinical signs;against feline panleucopenia to prevent mortality and clinical signs. onset of immunity is one week after primary vaccination course the duration of immunity is one year after the primary vaccination course and three years after the last re-vaccination.

PUREVAX RCPCH ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

purevax rcpch λυοφιλοποιημενο υλικο και διαλυτησ για ενεσιμο εναιωρημα

boehringer ingelheim vetmedica gmbh, ingelheim am rhein, germany (0000003115) -,55216,ingelheim/rhein,de - attenuated feline panleucopenia virus (pli iv); attenuated chlamydophila felis (905 strain); inactivated feline calicivirus (fcv 431 and g1 strains) antigens; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) - ΛΥΟΦΙΛΟΠΟΙΗΜΕΝΟ ΥΛΙΚΟ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ - attenuated feline panleucopenia virus (pli iv) 0,00 ly.insp.sv 0; attenuated chlamydophila felis (905 strain) 0,00 ly.insp.sv 0; inactivated feline calicivirus (fcv 431 and g1 strains) antigens 2,00 ly.insp.sv 0; attenuated feline rhinotracheitis herpesvirus (fhv f2 strain) 0,00 ly.insp.sv 0 - live feline rhinotracheitis virus + inactivated feline calicivirus antigen + live feline panleucopenia virus / parvovirus + live chlamydia - Γάτες - Χρόνοι αναμονής: Γάτες